Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$42.5B |
| 2 |
NVIDIA
NVDA
|
+$2.39B |
| 3 |
Walmart Inc
WMT
|
+$1.17B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 5 |
JPMorgan Chase
JPM
|
+$808M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Amazon
AMZN
|
+$843M |
| 3 |
Xcel Energy
XEL
|
+$674M |
| 4 |
Global Payments
GPN
|
+$623M |
| 5 |
Palantir
PLTR
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.22% |
| 2 | Technology | 18.11% |
| 3 | Financials | 7.1% |
| 4 | Communication Services | 5.53% |
| 5 | Consumer Discretionary | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3551
AdaptHealth
AHCO
$758M
| $236K | ﹤0.01% |
19,819
-140,128
| -88% | -$1.43M |
2022 Q1
16 quarters
|
|
3552
Pennant Group
PNTG
$1.35B
| $235K | ﹤0.01% |
7,698
-45,134
| -85% | -$1.4M |
2022 Q1
16 quarters
|
|
3553
Goosehead Insurance
GSHD
$1.12B
| $234K | ﹤0.01% |
5,491
-31,481
| -85% | -$1.76M |
2018 Q2
31 quarters
|
|
3554
Haleon
HLN
$38.3B
| $234K | ﹤0.01% |
23,363
-557,294
| -96% | -$5.8M |
2025 Q3
2 quarters
|
|
3555
Comstock
LODE
$171M
| $233K | ﹤0.01% |
76,510
+76,111
| +19,075% | +$249K |
2025 Q4
1 quarter
|
|
3556
MetroCity Bankshares
MCBS
$998M
| $233K | ﹤0.01% |
8,114
-30,596
| -79% | -$863K |
2019 Q4
25 quarters
|
|
3557
Enanta Pharmaceuticals
ENTA
$374M
| $232K | ﹤0.01% |
18,394
-36,595
| -67% | -$491K |
2013 Q2
51 quarters
|
|
|
RC
3558
Ready Capital
RC
$180M
| $232K | ﹤0.01% |
143,398
-211,712
| -60% | -$405K |
2017 Q1
36 quarters
|
|
3559
CALL
Atlassian
TEAM
$48.1B
| $232K | ﹤0.01% |
+3,400
| New | +$335K |
2026 Q1
0 quarters
|
|
3560
Bit Digital
BTBT
$584M
| $230K | ﹤0.01% |
175,642
-506,349
| -74% | -$930K |
2022 Q1
16 quarters
|
|
3561
Smith & Wesson
SWBI
$646M
| $230K | ﹤0.01% |
16,055
-57,837
| -78% | -$703K |
2022 Q1
16 quarters
|
|
3562
International Money Express
IMXI
$347M
| $230K | ﹤0.01% |
14,546
-60,092
| -81% | -$939K |
2019 Q1
28 quarters
|
|
|
ZOCT
3563
Innovator Equity Defined Protection ETF - 1 Yr October
ZOCT
$106M
| $229K | ﹤0.01% |
8,559
+6,336
| +285% | +$170K |
2024 Q4
5 quarters
|
|
3564
ZipRecruiter
ZIP
$293M
| $229K | ﹤0.01% |
124,353
-406,391
| -77% | -$997K |
2022 Q1
16 quarters
|
|
3565
Klaviyo
KVYO
$4.61B
| $229K | ﹤0.01% |
11,745
-46,547
| -80% | -$998K |
2024 Q1
8 quarters
|
|
|
HERE
3566
Here Group Ltd
HERE
$91.4M
| $228K | ﹤0.01% |
64,368
| – | – |
2025 Q2
3 quarters
|
|
3567
LSB Industries
LXU
$703M
| $228K | ﹤0.01% |
15,275
-68,675
| -82% | -$783K |
2022 Q2
15 quarters
|
|
3568
AdvanSix
ASIX
$431M
| $227K | ﹤0.01% |
9,309
-31,610
| -77% | -$597K |
2016 Q4
37 quarters
|
|
3569
Wipro
WIT
$17.4B
| $227K | ﹤0.01% |
107,044
+53,783
| +101% | +$131K |
2024 Q4
5 quarters
|
|
3570
American Vanguard Corp
AVD
$51.6M
| $226K | ﹤0.01% |
90,855
-35,414
| -28% | -$151K |
2013 Q2
51 quarters
|
|
3571
Schwab US Large-Cap Growth ETF
SCHG
$63.8B
| $225K | ﹤0.01% |
+7,720
| New | +$240K |
2026 Q1
0 quarters
|
|
3572
CALL
Regenxbio
RGNX
$490M
| $225K | ﹤0.01% |
26,800
| – | – |
2025 Q1
4 quarters
|
|
|
3573
PUT
Regenxbio
RGNX
$490M
| $225K | ﹤0.01% |
26,800
| – | – |
2025 Q1
4 quarters
|
|
|
DRUG
3574
Bright Minds Biosciences
DRUG
$485M
| $225K | ﹤0.01% |
3,077
-6,583
| -68% | -$530K |
2025 Q2
3 quarters
|
|
3575
Donnelley Financial Solutions
DFIN
$1.17B
| $224K | ﹤0.01% |
4,754
-35,104
| -88% | -$1.72M |
2016 Q4
37 quarters
|
|
Similar funds
Barclays's Q1 2026 Portfolio in Review
As of Q1 2026, Barclays held 5,572 positions worth $416B, down 0.11% from $417B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $42.4B of net new capital in Q1 2026, opening 397 new positions and adding to 1,219 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 44% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Tesla, an estimated $1.26B trimmed.
- Barclays's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q1 2026, an estimated $42.5B increase.
- Barclays's biggest Q1 2026 reduction was Tesla, cutting an estimated $1.26B.
- Barclays fully exited CyberArk in Q1 2026, selling an estimated $232M.
- Barclays's ten largest holdings make up 37% of its $416B portfolio in Q1 2026.
- Barclays opened 397 new positions and closed 563 in Q1 2026.
- Barclays's portfolio value fell 0.11% quarter-over-quarter to $416B.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.